Aprea Therapeutics (APRE) Stock Chart & Stock Price History $1.93 0.00 (0.00%) Closing price 03:59 PM EasternExtended Trading$1.95 +0.02 (+1.24%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aprea Therapeutics Stock Price Performance The Aprea Therapeutics (APRE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 50.13%, with a year-to-date return of -41.34%. In the past month, the stock has increased 18.77%, reflecting recent market activity. As of the latest close, Aprea Therapeutics traded at $1.93 with a market cap of $10.68 million and volume of 61,077 shares. Receive APRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+16.27%1 Month Performance+18.77%3 Month Performance+18.96%Year-To-Date Performance-41.34%1 Year Performance-50.13% APRE Stock Chart for Thursday, July, 24, 2025 APRE Chart by TradingView Aprea Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/24/2025$1.93$1.93$1.96$1.8939,129 shs$10.67 million07/23/2025$2.08$1.93-7.21%$2.22$1.9261,077 shs$10.68 million07/22/2025$1.73$2.08+20.23%$2.11$1.73130,944 shs$11.50 million07/21/2025$1.66$1.73+4.22%$1.80$1.6653,613 shs$9.57 million07/18/2025$1.67$1.66-0.60%$1.75$1.6393,479 shs$9.18 million07/17/2025$1.66$1.67+0.60%$1.78$1.6333,706 shs$9.24 million07/16/2025$1.63$1.66+1.84%$1.71$1.6358,608 shs$9.18 million07/15/2025$1.70$1.63-4.12%$1.69$1.6238,234 shs$9.01 million07/14/2025$1.73$1.70-1.73%$1.74$1.6144,024 shs$9.40 million07/11/2025$1.77$1.73-2.26%$1.86$1.6062,917 shs$9.57 million Get the Latest News and Ratings for APRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/10/2025$1.88$1.77-5.85%$1.97$1.7651,533 shs$9.79 million07/09/2025$1.80$1.88+4.44%$1.93$1.8072,492 shs$10.40 million07/08/2025$1.73$1.80+4.05%$1.87$1.7239,697 shs$9.95 million07/07/2025$1.75$1.73-1.14%$1.77$1.7024,480 shs$9.57 million07/04/2025$1.75$1.75$1.79$1.739,119 shs$9.68 million07/03/2025$1.70$1.75+2.94%$1.79$1.739,119 shs$9.68 million07/02/2025$1.65$1.70+3.03%$1.81$1.6533,450 shs$9.40 million07/01/2025$1.69$1.65-2.37%$1.72$1.6438,799 shs$9.12 million06/30/2025$1.68$1.69+0.90%$1.81$1.6842,645 shs$9.35 million06/27/2025$1.75$1.68-4.42%$1.80$1.6648,734 shs$9.26 million06/26/2025$1.80$1.75-2.64%$1.84$1.6382,482 shs$9.69 million06/25/2025$1.63$1.80+10.77%$1.91$1.48489,159 shs$9.95 million06/24/2025$1.60$1.63+1.56%$1.69$1.5817,489 shs$8.99 million06/23/2025$1.64$1.60-2.14%$1.67$1.5124,029 shs$8.85 million Related Companies CGTX Stock Chart KALA Stock Chart BDRX Stock Chart AKTX Stock Chart TELO Stock Chart COEP Stock Chart HYPD Stock Chart OKUR Stock Chart MAAQ Stock Chart KZR Stock Chart Receive APRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APRE) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aprea Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aprea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APRE Stock Alerts